Vext Science (VEXT) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
26 Dec, 2025Executive summary
2024 marked a pivotal year with strong operational execution, especially in Ohio, driving revenue and cash flow growth despite macroeconomic headwinds and pricing pressures in Arizona.
Q4 2024 was the strongest operating quarter in recent years, with significant contributions from Ohio's adult use market launch and continued execution in Arizona.
Ohio operations gained momentum, with Jackson and Columbus locations delivering ~40% sequential growth in Q4.
Regulatory approval received to complete the acquisition of two additional Ohio dispensaries, positioning the company to double its Ohio retail footprint.
Focus remains on retail-driven strategy, vertical integration, and disciplined cost controls to capture value and maintain market share.
Financial highlights
Fiscal 2024 revenue reached $36 million, up 3.4% year-over-year; Q4 revenue was $10.2 million, a 13% sequential increase.
Adjusted EBITDA for 2024 was $9.2 million (25% margin), a 66% increase year-over-year; Q4 adjusted EBITDA was $3.2 million (32% margin), up from $0.5 million in Q4 2023.
Cash flow from operations in Q4 2024 was $4 million, the highest in three years; full-year cash flow from operations was $3.3 million.
Ended 2024 with $4.6 million in cash and no anticipated need for capital raises for operational or expansion needs.
Net income after taxes for FY 2024 was $(22.4) million, compared to $4.4 million in FY 2023.
Outlook and guidance
Ohio expected to remain a key growth driver as new dispensaries open, with full vertical integration and license cap of eight stores targeted by early 2026.
Anticipates further strengthening of cash flow from operations in 2025 and 2026 as Ohio adult use market matures.
No plans for new retail acquisitions in Arizona in the near term; focus on optimizing existing footprint and evaluating future opportunities as market stabilizes.
Maintenance CapEx expected to remain under $2 million annually; new Ohio store build-outs budgeted at about $1 million per store, self-funded.
Plans to pay down $6.5 million in non-mortgage debt in 2025, targeting elimination of all non-mortgage debt by end of 2026.
Latest events from Vext Science
- Q2 revenue was $8.4M as Ohio adult-use launch drives growth outlook despite margin pressure.VEXT
Q2 202423 Jan 2026 - Q3 2024 revenue hit $9.0M with a 32% margin, fueled by Ohio adult-use and Arizona resilience.VEXT
Q3 202412 Jan 2026 - Record Q2 2025: $13.4M revenue, 31% cash flow margin, and 86% Ohio retail sales growth.VEXT
Q2 202523 Nov 2025 - Q3 revenue up 41% year-over-year to $12.7M, driven by Ohio retail and strong cash flow.VEXT
Q3 202520 Nov 2025 - Q1 2025 revenue up 38% to $11.6M, with record cash flow and Ohio retail expansion.VEXT
Q1 202513 Nov 2025 - Vertically integrated retail and cultivation in Arizona and Ohio fuel strong cash flow and growth.VEXT
Investor Presentation25 Jun 2025 - Retail-driven, vertically integrated operations fuel cash flow and growth in Arizona and Ohio.VEXT
Investor Presentation25 Jun 2025